Duane Nash, M.D., J.D., M.B.A, joined Immunic’s board as its chairman in 2019. Since April 2020, he has temporarily assumed the role of Executive Chairman.
From 2012 to 2019, Dr. Nash served in various leadership roles at Vital Therapies (Nasdaq: VTL), most recently as its Chief Executive Officer. Additional roles included Medical Director, Executive Vice President, Chief Business Officer and President. Prior to joining Vital Therapies, Dr. Nash held various positions at Wedbush PacGrowth Life Sciences, an investment bank, where he worked from 2009 to 2012, most recently as Senior Vice President in Equity Research. Before that, he was a research analyst at Pacific Growth Equities, which was acquired by Wedbush in 2009.
Dr. Nash also practiced law from 2002 to 2008, most recently at the law firm of Davis Polk & Wardwell, where he focused on intellectual property litigation and corporate matters. Dr. Nash served on the board of directors of Aerpio Pharmaceuticals (Nasdaq: ARPO) from 2012 to 2017, and Akebia Therapeutics (Nasdaq: AKBA) from 2013 to 2018.
Dr. Nash earned a B.A. in biology from Williams College, an M.D. from Dartmouth Medical School, a J.D. from the University of California, Berkeley, and an M.B.A. from the University of Oxford. Dr. Nash completed his internship in general surgery at the University of California, San Francisco.
What is Duane Nash's net worth?
The estimated net worth of Duane Nash is at least $24,014.88 as of May 12th, 2022. Dr. Nash owns 22,032 shares of Immunic stock worth more than $24,015 as of November 14th. This net worth evaluation does not reflect any other investments that Dr. Nash may own. Additionally, Dr. Nash receives a salary of $504,570.00 as Chairman at Immunic. Learn More about Duane Nash's net worth.
How old is Duane Nash?
Dr. Nash is currently 53 years old. There are 6 older executives and no younger executives at Immunic. The oldest executive at Immunic is Dr. Andreas Muehler M.D., Ph.D., Chief Medical Officer, who is 59 years old. Learn More on Duane Nash's age.
What is Duane Nash's salary?
As the Chairman of Immunic, Inc., Dr. Nash earns $504,570.00 per year. There are 3 executives that earn more than Dr. Nash. The highest earning executive at Immunic is Dr. Daniel Vitt Ph.D., CEO, President & Director, who commands a salary of $869,960.00 per year. Learn More on Duane Nash's salary.
How do I contact Duane Nash?
Has Duane Nash been buying or selling shares of Immunic?
Duane Nash has not been actively trading shares of Immunic in the last ninety days. Most recently, on Thursday, May 12th, Duane Nash bought 10,000 shares of Immunic stock. The stock was acquired at an average cost of $5.03 per share, with a total value of $50,300.00. Following the completion of the transaction, the chairman now directly owns 22,032 shares of the company's stock, valued at $110,820.96. Learn More on Duane Nash's trading history.
Who are Immunic's active insiders?
Are insiders buying or selling shares of Immunic?
In the last twelve months, Immunic insiders bought shares 1 times. They purchased a total of 87,300 shares worth more than $100,395.00. The most recent insider tranaction occured on November, 12th when Director Richard Alan Rudick bought 87,300 shares worth more than $100,395.00. Insiders at Immunic own 3.0% of the company.
Learn More about insider trades at Immunic. Information on this page was last updated on 11/12/2024.
